首页> 外文期刊>Chemistry Select >Fe(III)-Based Layered Double Hydroxides Carrying Model Naproxenate Anions:Compositional and Structural Aspects
【24h】

Fe(III)-Based Layered Double Hydroxides Carrying Model Naproxenate Anions:Compositional and Structural Aspects

机译:基于Fe(III)的分层双氢氧化物携带模型萘普生阴离子:成分和结构方面

获取原文
获取原文并翻译 | 示例
           

摘要

In this work,Al cation was gradually replaced by Fe~(III)in the composition of Layered Double Hydroxides(LDH)and systematically investigated for LDH application as drug carriers,ultimate aiming to improve their biointegration.The incorporation of Fe~(III)into LDH layers,as well the intercalation of organic anions in the iron-based materials,is challenging.Several studies approach the intercalation of non-steroidal antiinflammatory drugs such as anionic naproxen(NAP)into Al-LDH.Thus,NAP was applied here as a model drug for the study of compositional and structural aspects of novel FeIII-LDH carriers envisaging to shed light on the intercalation of other carboxylate drugs into these materials.LDH of general [M2FeyAl_((1-y))(OH)6]A~(n-)compositions(M~(II)=Mg or Zn;A~(n-)=anion of charge n)were investigated using two synthetic methods for NAP intercalation.Full X-ray diffraction profile refinement and a crystal-geometrical reasoning were used to strengthen the results interpretation.Unlike coprecipitation,in which probably NAP complexation with FeIII hinders LDH-NAP self-assembling,topotactic ion exchange demonstrated to be a potential approach.
机译:在这项工作中,Al阳离子在分层双氢氧化物(LDH)组成中逐渐被Fe〜(III)取代,并系统地研究了作为药物载体的LDH应用,最终旨在改善其生物整合。在铁基材料中有机阴离子的插入量很具有挑战性。作为研究新型FEIII-LDH携带者组成和结构方面的模型药物,设想将其他羧酸盐药物插入这些材料中。使用两种合成方法进行nap插入研究,研究了A〜(n-)组成(M〜(II)= mg或Zn; A〜(n-)=电荷n)。 - 使用地面推理来加强结果解释。共沉淀,其中可能与FEIII的小睡络合阻碍了LDH-NAP自组装,拓扑离子交换证明是一种潜在的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号